Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies (Q33371499)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies |
scientific article |
Statements
1 reference
Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies (English)
1 reference
Hervé Ghesquières
1 reference
Latifa Djafari
1 reference
Patricia Pautier
1 reference
Catherine Lhommé
1 reference
Stéphanie Lozahic
1 reference
Kamel Djazouli
1 reference
Jean-Pierre Armand
1 reference
Eric Raymond
1 reference
1 September 2006
1 reference
1 reference
24
1 reference
413-421
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference